dc.contributor.author | Stokstad, Trine | |
dc.contributor.author | Sørhaug, Sveinung | |
dc.contributor.author | Amundsen, Tore | |
dc.contributor.author | Grønberg, Bjørn Henning | |
dc.date.accessioned | 2021-05-28T07:25:03Z | |
dc.date.available | 2021-05-28T07:25:03Z | |
dc.date.created | 2021-05-20T09:31:43Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | In Vivo. 2021, 35 (3), 1595-1603. | en_US |
dc.identifier.issn | 0258-851X | |
dc.identifier.uri | https://hdl.handle.net/11250/2756752 | |
dc.description.abstract | Background: Time-to-treatment is defined as a quality indicator for cancer care but is not well documented. We investigated whether meeting Norwegian timeframes of 35/42 days from referral until start of chemotherapy or surgery/radiotherapy for lung cancer was associated with survival. Patients and Methods: The medical records of 439 lung cancer patients at a regional cancer center were reviewed and categorized according to treatment: (i) surgery; ii) radical radiotherapy; iii) stereotactic radiotherapy; iv) palliative treatment, no cancer symptoms; v) palliative treatment with severe cancer symptoms). Results: Proportions receiving timely treatment varied significantly at 39%, 48%, 10%, 44% and 89%, respectively (p<0.001). Overall, those starting treatment on time had the shortest median overall survival (10.6 vs. 22.6 months; p<0.001). This was also the case for palliative (5.3 vs. 11.4 months) (p<0.001) but not for curative treatment (not reached vs. 38.3 months) (p=0.038). Conclusion: Timely treatment is not necessarily associated with improved survival. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Highwire Press | en_US |
dc.title | Associations Between Time to Treatment Start and Survival in Patients With Lung Cancer | en_US |
dc.type | Peer reviewed | en_US |
dc.type | Journal article | en_US |
dc.description.version | publishedVersion | en_US |
dc.source.pagenumber | 1595-1603 | en_US |
dc.source.volume | 35 | en_US |
dc.source.journal | In Vivo | en_US |
dc.source.issue | 3 | en_US |
dc.identifier.doi | 10.21873/invivo.12416 | |
dc.identifier.cristin | 1910949 | |
dc.description.localcode | Copyright the Authors. Unrestricted non-commercial use, distribution and reproduction in any medium for academic reasons is allowed, provided that the original work is properly cited. | en_US |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |